Olon USA is the Early-Stage Drug Development part of Olon Group, a Global Leader in the Development and Production of Active Pharmaceutical Ingredients (APIs) for CDMO Partners and Generics. Olon provides an integrated package of chemical synthesis and biological processing services clients rely on to manage their manufacturing projects, in strict compliance with regulations. Our network of 11 manufacturing sites spans three continents (North America, Europe, and Asia) and includes seven R&D departments to support our pharmaceutical, chemical, biotech, and bio-industrial clients. Thanks to 2,500+ dedicated employees and 300 highly qualified people in R&D, we have a proven track record as a reliable partner. https://olonspa.com/ https://olonspa.com/generic-api/ https://olonricerca.com/